Cohen, Stanley
Pablos, Jose L.
Pavelka, Karel
Müller, Gerard Anton
Matsumoto, Alan
Kivitz, Alan
Wang, Hui
Krishnan, Eswar
Funding for this research was provided by:
Amgen (n/a)
Article History
Received: 31 August 2018
Accepted: 4 March 2019
First Online: 29 March 2019
Ethics approval and consent to participate
: This study was conducted in compliance with Institutional Review Board (IRB)/Independent Ethics Committee (IEC) and International Conference on Harmonisation (ICH) Good Clinical Practice (GCP) Guidelines - including Title 21 Part 56 of the US Code of Federal Regulations (CFR) relating to IRBs/IECs and GCP as described in the US Food and Drug Administration (FDA) CFR (21 CFR § 50, 56, 312) in accordance with applicable ICH regulations regarding clinical safety data management (E2A, E2B [R3]), European Community directives 2001/20, 2001/83, 2003/94 and 2005/28 as enacted into local law, and with ICH guidelines regarding scientific integrity (E4, E8, E9, and E10). In addition, this study was conducted in adherence to all local regulatory requirements, and requirements for data protection.
: Not applicable.
: Stanley Cohen is a consultant and investigator at Amgen, Abbvie, Boehringer Ingelheim, Coherus, Merck, Pfizer, and Sandoz.José Luis Pablos received honoraria for lectures and consultations from the following companies: BMS, Celgene, Gilead, Janssen, Lilly, Novartis, Pfizer, Roche, and Sanofi, and is also an investigator at Amgen.Karel Pavelka received honoraria for lectures and consultations from the following companies: AbbVie, Amgen, Biogen, BMS, MSD, Pfizer, Roche, and UCB.Gerard Anton Müller is an investigator at Amgen.Alan Matsumoto is a consultant and investigator at Amgen, Abbvie, Pfizer, and Takeda.Alan Kivitz is a consultant and part of the speakers’ bureau at Amgen, Abbvie, Pfizer, UCB, Merck, and Sanofi-Regeneron.Hui Wang is an employee and stockholder at Amgen.Eswar Krishnan is an employee and stockholder at Amgen (at the time this work was done).
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.